Carbon Dioxide
Colorectal Adenomas
Presidio Ospedaliero Santa BarbaraSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Colorectal Adenomas cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
UMBELLATINE Jing-yuan Fang, MD, Ph. D | Phase 2/3 | B |
Mesalamine UMC Utrecht | Phase 2 | B |
Dfn-15 University of Alabama at Birmingham | Phase 2 | B |
Linaclotide Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 | CCC |
Acetylsalicylic Acid University of Edinburgh | Phase 2 | CCC |
View all 11 →
Same molecule, other indications
Carbon Dioxide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →